Acer Therapeutics Inc. Quarterly Current Ratio in % from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Acer Therapeutics Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q3 2023.
  • Acer Therapeutics Inc. Current Ratio for the quarter ending September 30, 2023 was 14.8 %, a 81% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 14.8 -63.1 -81% Sep 30, 2023
Q2 2023 20.8 -66.5 -76.2% Jun 30, 2023
Q1 2023 35.3 -53 -60% Mar 31, 2023
Q4 2022 58.2 -37.1 -38.9% Dec 31, 2022
Q3 2022 77.9 -17.7 -18.5% Sep 30, 2022
Q2 2022 87.3 -17.5 -16.7% Jun 30, 2022
Q1 2022 88.3 -33.8 -27.7% Mar 31, 2022
Q4 2021 95.3 -82.1 -46.3% Dec 31, 2021
Q3 2021 95.6 -185 -65.9% Sep 30, 2021
Q2 2021 105 -335 -76.2% Jun 30, 2021
Q1 2021 122 -398 -76.5% Mar 31, 2021
Q4 2020 177 -486 -73.2% Dec 31, 2020
Q3 2020 280 -453 -61.8% Sep 30, 2020
Q2 2020 439 Jun 30, 2020
Q1 2020 520 Mar 31, 2020
Q4 2019 663 Dec 31, 2019
Q3 2019 733 Sep 30, 2019
Q2 2017 259 -20.1 -7.19% Jun 30, 2017
Q1 2017 236 -77.2 -24.6% Mar 31, 2017
Q4 2016 238 -52.2 -18% Dec 31, 2016
Q3 2016 251 -52 -17.1% Sep 30, 2016
Q2 2016 279 -40.8 -12.8% Jun 30, 2016
Q1 2016 313 -25.9 -7.64% Mar 31, 2016
Q4 2015 290 -179 -38.2% Dec 31, 2015
Q3 2015 303 -262 -46.3% Sep 30, 2015
Q2 2015 320 -301 -48.5% Jun 30, 2015
Q1 2015 339 -199 -36.9% Mar 31, 2015
Q4 2014 469 +14.1 +3.1% Dec 31, 2014
Q3 2014 565 +217 +62.4% Sep 30, 2014
Q2 2014 621 +434 +233% Jun 30, 2014
Q1 2014 538 +338 +169% Mar 31, 2014
Q4 2013 455 +270 +146% Dec 31, 2013
Q3 2013 348 +92.2 +36% Sep 30, 2013
Q2 2013 187 -322 -63.3% Jun 30, 2013
Q1 2013 200 -488 -70.9% Mar 31, 2013
Q4 2012 185 Dec 31, 2012
Q3 2012 256 Sep 30, 2012
Q2 2012 509 Jun 30, 2012
Q1 2012 688 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.